Christina Grothusen

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Angiotensin II induces MMP-2 in a p47phox-dependent manner

Maren Luchtefeld, Karsten Grote, Christina Grothusen et al. · Biochemical and Biophysical Research Communications · 2005 · 117 citations

Inflammation, Molecular Pharmacology, Hypertension +7

Chemokine Receptor 7 Knockout Attenuates Atherosclerotic Plaque Development

Maren Luchtefeld, Christina Grothusen, Andreas Gagalick et al. · Circulation · 2010 · 87 citations · Full text

Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial

Heribert Schunkert, Andreas Boening, Moritz von Scheidt et al. · European Heart Journal · 2019 · 84 citations · Full text

Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration

Karsten Grote, Harald Schuett, Gustavo Salguero et al. · Blood · 2010 · 81 citations · Full text